<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Novellas Healthcare</provider_name><provider_url>https://www.novellashealthcare.com/nl/</provider_url><author_name>rayan</author_name><author_url>https://www.novellashealthcare.com/nl/author/rayan/</author_url><title>Hoe Novellas Healthcare pati&#xEB;ntenbinding en therapietrouw versterkt in PSPs? | Novellas Healthcare</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="USNw5531Y5"&gt;&lt;a href="https://www.novellashealthcare.com/nl/blog-item/therapietrouw-versterkt-psp/"&gt;Hoe Novellas Healthcare pati&#xEB;ntenbinding en therapietrouw versterkt in PSPs?&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://www.novellashealthcare.com/nl/blog-item/therapietrouw-versterkt-psp/embed/#?secret=USNw5531Y5" width="600" height="338" title="&#x201C;Hoe Novellas Healthcare pati&#xEB;ntenbinding en therapietrouw versterkt in PSPs?&#x201D; &#x2014; Novellas Healthcare" data-secret="USNw5531Y5" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://www.novellashealthcare.com/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><description>In dit artikel bespreken we een casestudy waarin we laten zien hoe de expertise van Novellas Healthcare een farmaceutisch bedrijf hielp om grote uitdagingen op het gebied van therapietrouw voor een dermatologisch product te overwinnen. Door innovatieve, pati&#xEB;ntgerichte strategie&#xEB;n toe te passen, bereikten we een therapietrouw van 86% en verbeterden we de langdurige pati&#xEB;ntenbinding binnen het ondersteuningsprogramma.</description><thumbnail_url>https://www.novellashealthcare.com/wp-content/uploads/2022/05/Facebook.jpg</thumbnail_url><thumbnail_width>1200</thumbnail_width><thumbnail_height>630</thumbnail_height></oembed>
